Literature DB >> 18605364

Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines.

Moshe Mittelman1, Gilles Lugassy, Drorit Merkel, Hannah Tamary, Nadav Sarid, Eliezer Rachmilewitz, Chaim Hershko.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18605364

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  8 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 2.  Iron chelation therapy in myelodysplastic syndromes: where do we stand?

Authors:  Mhairi Mitchell; Steven D Gore; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2013-08       Impact factor: 2.929

Review 3.  Chelation therapy for iron overload: nursing practice implications.

Authors:  Ellen J Eckes
Journal:  J Infus Nurs       Date:  2011 Nov-Dec

4.  Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement.

Authors:  Bor-Sheng Ko; Cheng-Shyong Chang; Ming-Chih Chang; Tsai Yun Chen; Tzeon-Jye Chiou; Chang-Fang Chiu; Wen-Li Huang; Woei-Yau Kao; Yii-Jenq Lan; Shen-Fung Lin; Tran-Der Tan; Jih-Luh Tang; Cheng-Hwai Tzeng; Po-Nan Wang; Su-Pen Yet; Hwei-Fang Tien
Journal:  Int J Hematol       Date:  2014-06-13       Impact factor: 2.490

5.  Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes.

Authors:  Norbert Gattermann; Carlo Finelli; Matteo Della Porta; Pierre Fenaux; Michael Stadler; Agnes Guerci-Bresler; Mathias Schmid; Kerry Taylor; Dominique Vassilieff; Dany Habr; Andrea Marcellari; Bernard Roubert; Christian Rose
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

6.  Iron chelation therapy in myelodysplastic syndromes.

Authors:  Emanuela Messa; Daniela Cilloni; Giuseppe Saglio
Journal:  Adv Hematol       Date:  2010-06-20

7.  Deferasirox in a refractory anemia after other treatment options: case report and literature review.

Authors:  Palma Manduzio
Journal:  Clin Case Rep       Date:  2015-03-29

Review 8.  Role of serum ferritin level on overall survival in patients with myelodysplastic syndromes: Results of a meta-analysis of observational studies.

Authors:  Claudia Pileggi; Maddalena Di Sanzo; Valentina Mascaro; Maria Grazia Marafioti; Francesco Saverio Costanzo; Maria Pavia
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.